{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:34:59Z","timestamp":1794008099626,"version":"4.8.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.heliyon.2024.e38376","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T12:23:51Z","timestamp":1727180631000},"page":"e38376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Design, synthesis, biological evaluation, kinetic studies and molecular modeling of imidazo-isoxazole derivatives targeting both \u03b1-amylase and \u03b1-glucosidase inhibitors"],"prefix":"10.1016","volume":"10","author":[{"given":"Etab","family":"AlRashidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwar","family":"Ghannay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abuzar E.A.E.","family":"Albadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majdi","family":"Abid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Kadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiss","family":"Aouadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e38376_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e25911","article-title":"Identification of dual-target isoxazolidine-isatin hybrids with antidiabetic potential: design, synthesis, in vitro and multiscale molecular modeling approaches","volume":"10","author":"Ghannay","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2024.e38376_bib2","article-title":"Antidiabetic and hepatoprotection effect of butterfly pea flower (Clitoria ternatea L.) through antioxidant, anti-inflammatory, lower LDH, ACP, AST, and ALT on diabetes mellitus and dyslipidemia rat","volume":"10","author":"Widowati","year":"2024","journal-title":"Helyion"},{"key":"10.1016\/j.heliyon.2024.e38376_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12933-022-01560-2","article-title":"Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study","volume":"21","author":"Yun","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.heliyon.2024.e38376_bib4","article-title":"Potential effects of bisphenol A on diabetes mellitus and its chronic complications: a narrative review","volume":"9","author":"Jiang","year":"2023","journal-title":"Helyion"},{"key":"10.1016\/j.heliyon.2024.e38376_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1210\/endrev\/bnad030","article-title":"Protective factors and the pathogenesis of complications in diabetes","volume":"45","author":"Yu","year":"2024","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.heliyon.2024.e38376_bib6","article-title":"A systematic review of astragaloside IV effects on animal models of diabetes mellitus and its complications","volume":"10","author":"Qu","year":"2024","journal-title":"Helyion"},{"key":"10.1016\/j.heliyon.2024.e38376_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/ajm.ajm_53_20","article-title":"Pathophysiology of diabetes: an overview","volume":"10","author":"Banday","year":"2020","journal-title":"Avicenna J. Med."},{"key":"10.1016\/j.heliyon.2024.e38376_bib8","unstructured":"https:\/\/idf.org\/about-diabetes\/diabetes-facts-figures\/(assessed on 4\/9\/2024)."},{"key":"10.1016\/j.heliyon.2024.e38376_bib9","doi-asserted-by":"crossref","first-page":"8594","DOI":"10.3390\/ijerph17228594","article-title":"Prevalence of type 2 diabetes and its association with added sugar intake in citizens and refugees aged 40 or older in the gaza strip, Palestine","volume":"17","author":"Jebril","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.heliyon.2024.e38376_bib10","article-title":"Prevalence of type 2 diabetes mellitus and related factors among the general adult population in Saudi Arabia between 2016-2022: a systematic review and meta-analysis of the cross-sectional studies","volume":"16","author":"Alwadeai","year":"2023","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.heliyon.2024.e38376_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216514","article-title":"Natural inhibitors of mammalian \u03b1-amylases as promising drugs for the treatment of metabolic diseases","volume":"24","author":"Kalinovskii","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e38376_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.124572","article-title":"Unlocking potential diabetes therapeutics: insights into alpha-glucosidase inhibition","volume":"400","author":"Malik","year":"2024","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.heliyon.2024.e38376_bib13","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.1021\/acs.jmedchem.4c00676","article-title":"Identification of 1,3,4-thiadiazolyl-containing thiazolidine-2,4-dione derivatives as novel PTP1B inhibitors with antidiabetic activity","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115957","article-title":"Synthesis and biological evaluation of indole derivatives containing thiazolidine-2,4-dione as \u03b1- glucosidase inhibitors with antidiabetic activity","volume":"264","author":"Hu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116595","article-title":"Novel thiosemicarbazide-based \u03b2-carboline derivatives as \u03b1-glucosidase inhibitors: synthesis and biological evaluation","volume":"275","author":"Liang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107177","article-title":"Thiazolidine-2,4-dione derivatives as potential \u03b1-glucosidase inhibitors: synthesis, inhibitory activity, binding interaction and hypoglycemic activity","volume":"144","author":"Li","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138311","article-title":"Synthesis, anti-\u03b1- glucosidase activity, inhibition interaction, and anti-diabetic activity of novel cryptolepine derivatives","volume":"1310","author":"Feng","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.heliyon.2024.e38376_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135279","article-title":"New \u03b2-carboline derivatives as potential \u03b1-glucosidase inhibitor: synthesis and biological activity evaluation","volume":"1283","author":"Lin","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.heliyon.2024.e38376_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlumin.2024.120437","article-title":"Investigation on the inhibition mechanism and binding behavior of cryptolepine to \u03b1-glucosidase and its hypoglycemic activity by multi- spectroscopic method","volume":"269","author":"Min","year":"2024","journal-title":"J. Lumin."},{"key":"10.1016\/j.heliyon.2024.e38376_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.104072","article-title":"Synthesis and biological evaluation of coumarin derivatives containing oxime ester as \u03b1-glucosidase inhibitors","volume":"15","author":"Zhang","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2023.104659","article-title":"Synthesis and anti-\u03b1-glucosidase activity evaluation of betulinic acid derivatives","volume":"16","author":"Wu","year":"2023","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib22","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s11101-021-09773-1","article-title":"A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes","volume":"21","author":"Dirir","year":"2022","journal-title":"Phytochem Rev"},{"key":"10.1016\/j.heliyon.2024.e38376_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lwt.2021.112455","article-title":"Food-derived non-phenolic \u03b1-amylase and \u03b1-glucosidase inhibitors for controlling starch digestion rate and guiding diabetes- friendly recipes","volume":"153","author":"Li","year":"2022","journal-title":"LWT"},{"key":"10.1016\/j.heliyon.2024.e38376_bib24","article-title":"A comprehensive review of small- molecule drugs for the treatment of type 2 diabetes mellitus: synthetic approaches and clinical applications","volume":"5","author":"Guo","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib25","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1080\/00397911.2016.1244692","article-title":"Unprecedented stereoselective synthesis of 3-methylisoxazolidine-5-aryl-1,2,4- oxadiazoles via 1,3-dipolar cycloaddition and study of their in vitro antioxidant activity","volume":"46","author":"Brahmi","year":"2016","journal-title":"Synth. Commun."},{"key":"10.1016\/j.heliyon.2024.e38376_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09746","article-title":"Design and synthesis of novel enantiopure Bis(5-Isoxazolidine) derivatives: insights into their antioxidant and antimicrobial potential via in silico drug-likeness, pharmacokinetic, medicinal chemistry properties, and molecular docking studies","volume":"8","author":"Al-Adhreai","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2024.e38376_bib27","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.bmcl.2017.04.044","article-title":"Stereoselective synthesis of enantiopure N-substituted pyrrolidin-2,5-dione derivatives by 1,3-dipolar cycloaddition and assessment of their in vitro antioxidant and antibacterial activities","volume":"27","author":"Ghannay","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.heliyon.2024.e38376_bib28","article-title":"FDA-approved heterocyclic molecules for cancer treatment: synthesis, dosage, mechanism of action and their adverse effect","volume":"10","author":"Hossain","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2024.e38376_bib29","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11033-018-4523-y","article-title":"Synthesis and SPAR exploration of new semicarbazone-triazole hybrids in search of potent antioxidant, antibacterial and antifungal agents","volume":"46","author":"Brahmi","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.heliyon.2024.e38376_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104270","article-title":"Novel enantiopure isoxazolidine and C-alkyl imine oxide derivatives as potential hypoglycemic agents: design, synthesis, dual inhibitors of \u03b1-amylase and \u03b1-glucosidase, ADMET and molecular docking study","volume":"104","author":"Ghannay","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib31","first-page":"7480","article-title":"New 1,3,4-thiadiazole derivatives as \u03b1- glucosidase inhibitors: design, synthesis, DFT, ADME, and in vitro enzymatic studies","volume":"9","author":"Ali","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.heliyon.2024.e38376_bib32","doi-asserted-by":"crossref","first-page":"18011","DOI":"10.1039\/D4RA02567A","article-title":"Exploring the latest trends in chemistry, structure, coordination, and diverse applications of 1-acyl-3- substituted thioureas: a comprehensive review","volume":"14","author":"Ullah","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.heliyon.2024.e38376_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116523","article-title":"Exploring fluorine- substituted piperidines as potential therapeutics for diabetes mellitus and Alzheimer's diseases","volume":"273","author":"Mughal","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib34","doi-asserted-by":"crossref","first-page":"47251","DOI":"10.1021\/acsomega.2c06513","article-title":"Synthesis and evaluation of amide and thiourea derivatives as carbonic anhydrase (CA) inhibitors","volume":"7","author":"Zahid","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.heliyon.2024.e38376_bib35","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1039\/D1MD00058F","article-title":"Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis","volume":"12","author":"Ronchetti","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib36","doi-asserted-by":"crossref","first-page":"9488","DOI":"10.3390\/ijms24119488","article-title":"Design, synthesis and biological activities of (Thio)Urea benzothiazole derivatives","volume":"24","author":"Mendieta-Wejebe","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e38376_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112402","article-title":"Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors","volume":"199","author":"Do\u011fan","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133284","article-title":"Novel urea- thiourea hybrids bearing 1,4-naphthoquinone moiety: anti-inflammatory activity on mammalian macrophages by regulating intracellular PI3K pathway, and molecular docking study","volume":"1264","author":"Efeoglu","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.heliyon.2024.e38376_bib39","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1021\/acs.jmedchem.9b01541","article-title":"Urea derivatives in modern drug discovery and medicinal chemistry","volume":"63","author":"Ghosh","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib40","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s11030-022-10543-0","article-title":"Isoxazole carboxylic acid methyl ester-based urea and thiourea derivatives as promising antitubercular agents","volume":"27","author":"Sahoo","year":"2023","journal-title":"Mol. Divers."},{"key":"10.1016\/j.heliyon.2024.e38376_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11523-016-0467-0","article-title":"Phase I\/II randomized trial of Sorafenib and bevacizumab as first-line therapy in patients with locally advanced or metastatic hepatocellular carcinoma: north central cancer treatment group trial N0745 (alliance)","volume":"12","author":"Hubbard","year":"2017","journal-title":"Target Oncol"},{"key":"10.1016\/j.heliyon.2024.e38376_bib42","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/bjc.1994.125","article-title":"Pharmacokinetics in melanoma- bearing mice of 5-dihydroxyboryl-6-propyl-2-thiouracil (BPTU), a candidate compound for boron neutron capture therapy","volume":"69","author":"Verrijk","year":"1994","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e38376_bib43","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1124\/mol.117.109660","article-title":"Distinct signaling patterns of allosteric antagonism at the P2Y1 receptor","volume":"92","author":"Gao","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e38376_bib44","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1039\/D1OB02080C","article-title":"Fluorescently labelled thioacetazone for detecting the interaction with Mycobacterium dehydratases HadAB and HadBC","volume":"20","author":"Singh","year":"2022","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib45","first-page":"145","article-title":"Chapter 12 - dermatological drugs, topical agents, and cosmetics","volume":"vol. 39","author":"Black","year":"2017"},{"key":"10.1016\/j.heliyon.2024.e38376_bib46","unstructured":"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-enzalutamide-non-metastatic-castration-sensitive-prostate-cancer-biochemical-recurrence."},{"key":"10.1016\/j.heliyon.2024.e38376_bib47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.55071\/ticaretfbd.1364818","article-title":"Synthesis of 2-fluorobenzoyl thiourea derivatives","volume":"22","author":"Erol G\u00fcnal","year":"2023","journal-title":"\u0130stanbul Ticaret \u00dcniversitesi Fen Bilimleri Dergisi"},{"key":"10.1016\/j.heliyon.2024.e38376_bib48","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1093\/eurjpc\/zwad084","article-title":"Glimepiride: an old antidiabetic medication with potential as a new cardiovascular therapeutic?","volume":"30","author":"Sawami","year":"2023","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e38376_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111400","article-title":"A colorimetric method for screening \u03b1-glucosidase inhibitors from flavonoids using 3,3',5,5'-tetramethylbenzidine as a chromogenic probe","volume":"197","author":"Liu","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.heliyon.2024.e38376_bib50","article-title":"Phytochemical characterization and multifaceted bioactivity assessment of essential oil from Ptychotis verticillata Duby: anti-diabetic, anti-tyrosinase, and anti-inflammatory activity","volume":"10","author":"Taibi","year":"2024","journal-title":"Helyion"},{"key":"10.1016\/j.heliyon.2024.e38376_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28782","article-title":"The risk factors for mental health disorders in patients with type 2 diabetes: an umbrella review of systematic reviews with and without meta-analysis","volume":"10","author":"Busili","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2024.e38376_bib52","article-title":"Influence of glutamine metabolism on diabetes Development: a scientometric review","volume":"10","author":"Zhao","year":"2024","journal-title":"Helyion"},{"key":"10.1016\/j.heliyon.2024.e38376_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24470","article-title":"Anti-enzymatic and DNA docking studies of montelukast: a multifaceted molecular scaffold with in vitro investigations, molecular expression analysis and molecular dynamics simulations","volume":"10","author":"Abdullah","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2024.e38376_bib54","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/molecules29020305","article-title":"In silico design, synthesis, and evaluation of novel enantiopure isoxazolidines as promising dual inhibitors of \u03b1-amylase and \u03b1- glucosidase","volume":"29","author":"Alhawday","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e38376_bib55","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.3390\/molecules27217248","article-title":"Multifunctional derivatives of spiropyrrolidine tethered indeno-quinoxaline heterocyclic hybrids as potent antimicrobial, antioxidant and antidiabetic agents: design, synthesis, in vitro and in silico approaches","volume":"27","author":"Bouali","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e38376_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103713","article-title":"Multifunctional isoxazolidine derivatives as \u03b1-amylase and \u03b1-glucosidase inhibitors","volume":"98","author":"Ghabi","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib57","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/ph16071025","article-title":"In vitro and in silico evaluation of antiproliferative activity of new isoxazolidine derivatives targeting EGFR: design, synthesis, cell cycle analysis, and apoptotic inducers","volume":"16","author":"Alminderej","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.heliyon.2024.e38376_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128651","article-title":"Novel fused pyridine derivatives containing pyrimidine moiety as prospective tyrosyl-tRNA synthetase inhibitors: design, synthesis, pharmacokinetics and molecular docking studies","volume":"1219","author":"Othman","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.heliyon.2024.e38376_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104105","article-title":"Design, synthesis ADMET and molecular docking of new imidazo[4,5- b]pyridine-5-thione derivatives as potential tyrosyl-tRNA synthetase inhibitors","volume":"102","author":"Othman","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133312","article-title":"Design, synthesis, in vitro anticancer and antimicrobial evaluation, SAR analysis, molecular docking and dynamic simulation of new pyrazoles, triazoles and pyridazines based isoxazole","volume":"1264","author":"Radwan","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.heliyon.2024.e38376_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133299","article-title":"Novel (2-Oxoindolin- 3-ylidene)methyl)-1H-pyrazole and their fused derivatives: design, synthesis, antimicrobial evaluation, DFT, chemical approach, in silico ADME and molecular docking studies","volume":"1264","author":"El-Qaliei","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.heliyon.2024.e38376_bib62","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1002\/slct.202101622","article-title":"Synthesis, structure\u2010activity relationship and in silico studies of novel pyrazolothiazole and thiazolopyridine derivatives as prospective antimicrobial and anticancer agents","volume":"6","author":"Othman","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.heliyon.2024.e38376_bib63","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/antiox9101003","article-title":"Allium subhirsutum L. As a potential source of antioxidant and anticancer bioactive molecules: HR-LCMS phytochemical profiling, in vitro and in vivo pharmacological study","volume":"9","author":"Badraoui","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.heliyon.2024.e38376_bib64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00706-020-02550-4","article-title":"Synthesis, in vitro antimicrobial assessment, and computational investigation of pharmacokinetic and bioactivity properties of novel trifluoromethylated compounds using in silico ADME and toxicity prediction tools","volume":"151","author":"Ghannay","year":"2020","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104704","article-title":"New substituted pyrazolones and dipyrazolotriazines as promising tyrosyl-tRNA synthetase and peroxiredoxin-5 inhibitors: design, synthesis, molecular docking and structure-activity relationship (SAR) analysis","volume":"109","author":"Othman","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132960","article-title":"Synthesis, crystal structures, \u03b1-glucosidase and \u03b1-amylase inhibition, DFT and molecular docking investigations of two thiazolidine-2,4-dione derivatives","volume":"1261","author":"Thari","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.heliyon.2024.e38376_bib67","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3390\/molecules24081511","article-title":"Novel C-2 symmetric molecules as \u03b1-glucosidase and \u03b1-amylase inhibitors: design, synthesis, kinetic evaluation, molecular docking and pharmacokinetics","volume":"24","author":"Shahzad","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e38376_bib68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/bj3460201","article-title":"Crystal structures of human pancreatic \u03b1-amylase in complex with carbohydrate and proteinaceous inhibitors","volume":"346","author":"Nahoum","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.heliyon.2024.e38376_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.104301","article-title":"Synthesis, \u03b1-glucosidase inhibition and molecular docking studies of natural product 2-(2- phenyethyl)chromone analogues","volume":"15","author":"Fan","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.heliyon.2024.e38376_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112013","article-title":"Synthesis and biological evaluation of coumarin derivatives as alpha-glucosidase inhibitors","volume":"189","author":"Xu","year":"2020","journal-title":"Eur. J. Med. Chem."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024144076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024144076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:09:17Z","timestamp":1775729357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024144076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":70,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2405844024144076"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38376","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, biological evaluation, kinetic studies and molecular modeling of imidazo-isoxazole derivatives targeting both \u03b1-amylase and \u03b1-glucosidase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e38376"}}